Dr. Douglas Francis Beach, MD

Dr. Beach practices at Pennsylvania Hospital in Philadelphia, Pennsylvania, part of University of Pennsylvania.

Dr. Beach's NPI, 1457598930, was assigned on January 20, 2009. Dr. Beach graduated from Rutgers Robert Wood Johnson Medical School in 2006. Dr. Beach holds Pennsylvania license MD445801.

Dr. Beach's primary practice is Pennsylvania Hospital, at 800 Spruce Street, Philadelphia, PA 19107 in Philadelphia County. The practice phone is (215) 829-3000.

Dr. Beach's primary practice is Pennsylvania Hospital in Philadelphia, Pennsylvania, part of University of Pennsylvania. Dr. Beach is also affiliated with Hospital of the University of Pennsylvania. The medical group on file is Penn Medicine Lancaster General Health. Dmand AI also links Dr. Beach to 1 more hospital, 1 group practice or clinic, 1 home health agency and 1 hospice, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Beach practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Beach's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Beach is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Beach's licenses on file in 2 states: Pennsylvania and New Jersey.

Dmand AI lists anemia, breast cancer, chronic anemia, chronic leukemia, deep vein thrombosis (DVT), immune deficiency disease, lung cancer and lymphoma among the conditions Dr. Beach treats.

CMS data shows 1,093 Medicare services from Dr. Beach across 12 procedure codes in 2024, for 310 Medicare patients. Medicare paid $72,153 for them.

CMS counts 310 Medicare patients who saw Dr. Beach in 2024. The largest group is 65 to 74, with 130 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 19% are also on Medicaid. Their average risk score is 1.79, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Beach's median patient age at 61, with 71% women.

In 2024, Dr. Beach wrote 764 Medicare Part D claims for 182 patients. 75% of them were for generic drugs. CMS names the drug for 550 of them, across 25 drugs with 11 or more claims each, at $1,004,631 in total drug cost. In 2023, CMS named 378 claims across 16 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Beach for performance year 2024, reported as part of a group. Dr. Beach accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Beach as offering telehealth.

Dmand AI links 16 papers to Dr. Beach, published from 2011 to 2021. 2011 was the busiest year, with 6. The most frequent topics are Pulmonary Disease, Chronic Obstructive, Tai Ji and Dyspnea. Dr. Beach's most frequent co-authors are Douglas M. Beach, MD, Elizabeth S. Klings, MD and Robert A. Somer, MD.

Dmand AI links Dr. Beach to 6 clinical trials, 2 of them phase 1 studies. 1 is still active or recruiting. Conditions studied include Lymphoma, B-Cell, HIV Infections and Leukemia, Lymphocytic, Chronic, B-Cell. National Cancer Institute (NCI) sponsors the most, 3.

CMS Open Payments shows 34 general payments to Dr. Beach from 12 drug and device companies from 2018 to 2025. Consulting fees make up the largest share, 50% of the total. AstraZeneca Pharmaceuticals LP paid the most, $3,449.

Dr. Beach graduated from Rutgers Robert Wood Johnson Medical School in 2006.

Dr. Beach is in network with 18 carriers, including Aetna, Elevance and United Healthcare. HMO plans come from the most carriers, 11. Check the plan with the practice before a visit.